DCM
TMO icon

Davis Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Davis Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$915K Buy
1,356
+746
+122% +$443K 0.55% 48
2026
Q2 		$306K Buy
610
+606
+15,150% +$291K 0.18% 70
2026
Q1 		$1.97K Sell
4
-1
-20% -$543 ﹤0.01% 293
2025
Q4 		$2.9K Hold
5
– – ﹤0.01% 283
2025
Q3 		$2.42K Buy
+5
New +$2.33K ﹤0.01% 292

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Davis Capital Management's TMO Position: Q3 2026 in Review

Davis Capital Management increased its Thermo Fisher Scientific (TMO) stake by 122% in Q3 2026, buying an estimated $443K and bringing the position to 1,356 shares worth $915K. The position accounts for 0.55% of the portfolio, ranked #48.

Davis Capital Management first reported a position in TMO in Q3 2025 and has held it in 5 quarters since. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Davis Capital Management held 1,356 shares of Thermo Fisher Scientific worth $915K as of Q3 2026.
  • Davis Capital Management bought 746 Thermo Fisher Scientific shares in Q3 2026, an estimated $443K.
  • Thermo Fisher Scientific made up 0.55% of Davis Capital Management's portfolio in Q3 2026, its #48 holding.
  • Davis Capital Management first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 5 quarters since.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.